NASDAQ:SCPH - Scpharmaceuticals Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$5.37 +0.23 (+4.47 %)
(As of 08/19/2018 11:23 AM ET)
Previous Close$5.37
Today's Range$5.10 - $5.6399
52-Week Range$4.10 - $18.17
Volume124,964 shs
Average Volume100,953 shs
Market Capitalization$85.11 million
P/E Ratio-0.67
Dividend YieldN/A
BetaN/A
Scpharmaceuticals logoscPharmaceuticals Inc., a clinical-stage pharmaceutical company, engages in the development and commercialization of various pharmaceutical products. The company's lead product candidate is Furoscix, a drug-device combination product that is under development for treatment of worsening or decompensated heart failure outside of the inpatient setting. Its product pipeline also includes scFurosemide, a loop diuretic for the management of edema in patients with decompensated heart failure; scCeftriaxone, an antibiotic to treat infections caused by gram-positive and gram-negative organisms; and scCarbapenem program, an antibiotic for treating infections caused by gram-negative organisms. The company was founded in 2013 and is headquartered in Burlington, Massachusetts.

Receive SCPH News and Ratings via Email

Sign-up to receive the latest news and ratings for SCPH and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange NASDAQ
Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
SymbolNASDAQ:SCPH
CUSIPN/A
Phone617-517-0730

Debt

Debt-to-Equity Ratio0.10
Current Ratio19.23
Quick Ratio19.23

Price-To-Earnings

Trailing P/E Ratio-0.67
Forward P/E Ratio-2.42
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book Value$6.02 per share
Price / Book0.89

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

Employees29
Outstanding Shares18,570,000
Market Cap$85.11 million

Scpharmaceuticals (NASDAQ:SCPH) Frequently Asked Questions

What is Scpharmaceuticals' stock symbol?

Scpharmaceuticals trades on the NASDAQ under the ticker symbol "SCPH."

How were Scpharmaceuticals' earnings last quarter?

Scpharmaceuticals Inc (NASDAQ:SCPH) issued its quarterly earnings data on Tuesday, August, 14th. The company reported ($0.53) earnings per share (EPS) for the quarter, topping the Thomson Reuters' consensus estimate of ($0.57) by $0.04. View Scpharmaceuticals' Earnings History.

When is Scpharmaceuticals' next earnings date?

Scpharmaceuticals is scheduled to release their next quarterly earnings announcement on Tuesday, November, 13th 2018. View Earnings Estimates for Scpharmaceuticals.

What price target have analysts set for SCPH?

3 Wall Street analysts have issued 1 year price objectives for Scpharmaceuticals' shares. Their predictions range from $12.00 to $14.00. On average, they expect Scpharmaceuticals' stock price to reach $12.6667 in the next year. This suggests a possible upside of 135.9% from the stock's current price. View Analyst Price Targets for Scpharmaceuticals.

What is the consensus analysts' recommendation for Scpharmaceuticals?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Scpharmaceuticals in the last year. There are currently 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Scpharmaceuticals.

Who are some of Scpharmaceuticals' key competitors?

Who are Scpharmaceuticals' key executives?

Scpharmaceuticals' management team includes the folowing people:
  • Mr. John H. Tucker, Pres, CEO & Director (Age 55)
  • Dr. Troy A. Ignelzi, Chief Financial Officer (Age 50)
  • Mr. Abraham Ceesay, Chief Operating Officer (Age 40)
  • Dr. Pieter Muntendam M.D., Consultant (Age 60)
  • Katherine Taudvin, Director of Corp. Devel. & Investor Relations

When did Scpharmaceuticals IPO?

(SCPH) raised $96 million in an IPO on Friday, November 17th 2017. The company issued 6,400,000 shares at a price of $14.00-$16.00 per share. Jefferies, Leerink Partners and BMO Capital Markets acted as the underwriters for the IPO.

Has Scpharmaceuticals been receiving favorable news coverage?

Media coverage about SCPH stock has trended somewhat positive recently, Accern Sentiment reports. The research group ranks the sentiment of media coverage by monitoring more than twenty million blog and news sources. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Scpharmaceuticals earned a news and rumor sentiment score of 0.17 on Accern's scale. They also assigned press coverage about the company an impact score of 48.57 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the stock's share price in the immediate future. View Recent Headlines for Scpharmaceuticals.

Who are Scpharmaceuticals' major shareholders?

Scpharmaceuticals' stock is owned by many different of institutional and retail investors. Top institutional investors include BlackRock Inc. (1.88%), Acadian Asset Management LLC (0.16%) and Colony Group LLC (0.13%). View Institutional Ownership Trends for Scpharmaceuticals.

Which institutional investors are buying Scpharmaceuticals stock?

SCPH stock was purchased by a variety of institutional investors in the last quarter, including BlackRock Inc., Acadian Asset Management LLC and Colony Group LLC. View Insider Buying and Selling for Scpharmaceuticals.

How do I buy shares of Scpharmaceuticals?

Shares of SCPH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Scpharmaceuticals' stock price today?

One share of SCPH stock can currently be purchased for approximately $5.37.

How big of a company is Scpharmaceuticals?

Scpharmaceuticals has a market capitalization of $85.11 million. The company earns $-23,810,000.00 in net income (profit) each year or ($8.04) on an earnings per share basis. Scpharmaceuticals employs 29 workers across the globe.

How can I contact Scpharmaceuticals?

Scpharmaceuticals' mailing address is 2400 DISTRICT AVENUE SUITE 310, BURLINGTON MA, 01830. The company can be reached via phone at 617-517-0730 or via email at [email protected]


MarketBeat Community Rating for Scpharmaceuticals (NASDAQ SCPH)

Community Ranking:  2.6 out of 5 (star star)
Outperform Votes:  54 (Vote Outperform)
Underperform Votes:  48 (Vote Underperform)
Total Votes:  102
MarketBeat's community ratings are surveys of what our community members think about Scpharmaceuticals and other stocks. Vote "Outperform" if you believe SCPH will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SCPH will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 8/19/2018 by MarketBeat.com Staff

Featured Article: How Short Selling Works

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.